Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+1.04%
adds when stocks drop
when a holding falls −10%+
Middle response
-4.30%
baseline attrition
Rally response
+9.49%
adds into rallies
when a holding rises +10%+
Top positions · 2
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| MLYSMineralys Therapeutics, | $214M | 92.8% | +70.6% | 2.5 yr |
| PHATPhathom Pharmaceuticals, | $17M | 7.2% | +77.2% | 2.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+0.0pp$231M
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Top buys this quarter · 1
| PHAT Phathom Pharmaceuticals, Inc. | +$17M |
Top sells this quarter · 0
No sells this quarter
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $231M | 2 | +70.57% | +17.59% | +52.97% | +0.00B |
| 2025-12-31 | $311M | 2 | +187.34% | +17.72% | +169.62% | -0.03B |
| 2025-09-30 | $351M | 2 | +172.50% | +17.52% | +154.98% | +0.00B |
| 2025-06-30 | $132M | 2 | +10.44% | +14.94% | -4.50% | -0.00B |
| 2025-03-31 | $149M | 2 | +13.53% | +8.30% | +5.23% | +0.00B |
| 2024-12-31 | $116M | 2 | +34.23% | +24.89% | +9.35% | -0.00B |
| 2024-09-30 | $125M | 3 | +8.16% | +5.75% | +2.41% | -0.02B |
| 2024-06-30 | $132M | 3 | -8.99% | +4.38% | -13.37% | -0.00B |
| 2024-03-31 | $148M | 3 | +47.52% | +10.39% | +37.12% | -0.01B |
| 2023-12-31 | $107M | 3 | — | — | — | — |